To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html

Key Market Insights
 More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug device combinations
 Companies focused on developing devices for the delivery of insulin have already established strong brand positions in this domain, with 30+ devices currently under development or available
 More than 200 biologics / small molecule drugs were identified as likely products to be developed in combination with large volume wearable injectors
 The rising interest in this field is reflected in the number of partnerships (90+) inked between 2015
and 2020 (till June), involving both international and indigenous stakeholders, across the world
 An evaluation of 50+ stakeholders engaged in the development of large volume wearable injectors revealed the existence of several likely acquisition targets, across different geographical regions
 The market, for the large volume wearable injectors for the delivery of non-insulin drugs is projected to be worth USD 600 million; owing to the increasing incidence of chronic clinical conditions and growing pipeline of therapeutic interventions to treat such diseases
 The large volume wearable injectors market for insulin is anticipated to be worth over USD 2.7 billion by 2030; the anticipated opportunity is likely to be distributed across various different device types, therapeutic areas and geographies

For more information, please visit https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html


Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]